PT71755A - Process for preparing 4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase - Google Patents
Process for preparing 4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidaseInfo
- Publication number
- PT71755A PT71755A PT71755A PT7175580A PT71755A PT 71755 A PT71755 A PT 71755A PT 71755 A PT71755 A PT 71755A PT 7175580 A PT7175580 A PT 7175580A PT 71755 A PT71755 A PT 71755A
- Authority
- PT
- Portugal
- Prior art keywords
- pyrroline
- hydroxy
- glycolic acid
- acid oxidase
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/074,465 US4298743A (en) | 1979-09-11 | 1979-09-11 | 4-(Substituted phenyl thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT71755A true PT71755A (en) | 1980-09-01 |
| PT71755B PT71755B (en) | 1982-03-19 |
Family
ID=22119703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT71755A PT71755B (en) | 1979-09-11 | 1980-08-29 | Process for preparing 4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4298743A (pt) |
| EP (1) | EP0025232B1 (pt) |
| JP (1) | JPS5646809A (pt) |
| AT (1) | ATE2271T1 (pt) |
| DE (1) | DE3061688D1 (pt) |
| DK (1) | DK384280A (pt) |
| ES (1) | ES494933A0 (pt) |
| GR (1) | GR70200B (pt) |
| PT (1) | PT71755B (pt) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4379791A (en) * | 1979-09-11 | 1983-04-12 | Merck & Co., Inc. | 4-(Substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase |
| US4700901A (en) * | 1985-08-19 | 1987-10-20 | Breville R & D Pty. Limited | Food processors |
| ES2245660T3 (es) * | 1990-11-30 | 2006-01-16 | Otsuka Pharmaceutical Co., Ltd. | Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos. |
| MY128323A (en) * | 1996-09-30 | 2007-01-31 | Otsuka Pharma Co Ltd | Thiazole derivatives for inhibition of cytokine production and of cell adhesion |
| US6313156B1 (en) * | 1999-12-23 | 2001-11-06 | Icos Corporation | Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors |
| DE10029077A1 (de) | 2000-06-13 | 2001-12-20 | Bayer Ag | Thiazolylsubstituierte Heterocyclen |
| EP3042894A1 (en) * | 2001-08-10 | 2016-07-13 | Shionogi & Co., Ltd. | Antiviral agent |
| US6858614B2 (en) * | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenolic guanidine sodium channel blockers |
| US6858615B2 (en) * | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
| US7279576B2 (en) | 2002-12-31 | 2007-10-09 | Deciphera Pharmaceuticals, Llc | Anti-cancer medicaments |
| US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
| US7202257B2 (en) | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| US6903105B2 (en) | 2003-02-19 | 2005-06-07 | Parion Sciences, Inc. | Sodium channel blockers |
| US7745442B2 (en) | 2003-08-20 | 2010-06-29 | Parion Sciences, Inc. | Methods of reducing risk of infection from pathogens |
| CA2592118C (en) | 2004-12-23 | 2015-11-17 | Deciphera Pharmaceuticals, Llc | Urea derivatives as enzyme modulators |
| US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| US7790756B2 (en) | 2006-10-11 | 2010-09-07 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| AU2008251723A1 (en) | 2007-04-20 | 2008-11-20 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| KR20110099687A (ko) | 2008-10-29 | 2011-09-08 | 데시페라 파마슈티칼스, 엘엘씨. | 항-암과 항-증식성 활성을 나타내는 시클로프로판 아미드와 유사체 |
| AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
| US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| KR20150095870A (ko) | 2012-12-17 | 2015-08-21 | 패리온 사이언스 인코퍼레이티드 | 3,5-디아미노-6-클로로-n-(n-(4-페닐부틸)카르밤이미도일)피라진-2-카르복스아미드 화합물 |
| AU2013363218B2 (en) | 2012-12-17 | 2018-03-15 | Parion Sciences, Inc. | Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration |
| US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
| CA3089630A1 (en) | 2018-01-31 | 2019-08-08 | Deciphera Pharmaceuticals, Llc | Combination therapy for the treatment of mastocytosis |
| SG11202007198WA (en) | 2018-01-31 | 2020-08-28 | Deciphera Pharmaceuticals Llc | Combination therapy for the treatment of gastrointestinal stromal tumors |
| TW202122082A (zh) | 2019-08-12 | 2021-06-16 | 美商迪賽孚爾製藥有限公司 | 治療胃腸道基質瘤方法 |
| EP4013412A1 (en) | 2019-08-12 | 2022-06-22 | Deciphera Pharmaceuticals, LLC | Ripretinib for treating gastrointestinal stromal tumors |
| EP4084779B1 (en) | 2019-12-30 | 2024-10-09 | Deciphera Pharmaceuticals, LLC | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea |
| EP4084778B1 (en) | 2019-12-30 | 2023-11-01 | Deciphera Pharmaceuticals, LLC | Amorphous kinase inhibitor formulations and methods of use thereof |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE599556A (pt) * | 1960-02-01 | |||
| US3340263A (en) * | 1964-02-14 | 1967-09-05 | Ciba Geigy Corp | Amino-pyrroles |
| GB1127875A (en) * | 1967-03-23 | 1968-09-18 | Parke Davis & Co | 4-(5-nitro-2-furyl) thiazolyl hydantoins and hydrouracils |
| GB1304174A (pt) * | 1969-03-07 | 1973-01-24 |
-
1979
- 1979-09-11 US US06/074,465 patent/US4298743A/en not_active Expired - Lifetime
-
1980
- 1980-08-29 PT PT71755A patent/PT71755B/pt unknown
- 1980-09-08 GR GR62835A patent/GR70200B/el unknown
- 1980-09-10 ES ES494933A patent/ES494933A0/es active Granted
- 1980-09-10 EP EP80105409A patent/EP0025232B1/en not_active Expired
- 1980-09-10 AT AT80105409T patent/ATE2271T1/de not_active IP Right Cessation
- 1980-09-10 DK DK384280A patent/DK384280A/da not_active Application Discontinuation
- 1980-09-10 DE DE8080105409T patent/DE3061688D1/de not_active Expired
- 1980-09-11 JP JP12536980A patent/JPS5646809A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PT71755B (en) | 1982-03-19 |
| ATE2271T1 (de) | 1983-02-15 |
| US4298743A (en) | 1981-11-03 |
| ES8105996A1 (es) | 1981-07-01 |
| DK384280A (da) | 1981-03-12 |
| JPS5646809A (en) | 1981-04-28 |
| EP0025232A1 (en) | 1981-03-18 |
| GR70200B (pt) | 1982-08-31 |
| EP0025232B1 (en) | 1983-01-19 |
| ES494933A0 (es) | 1981-07-01 |
| DE3061688D1 (en) | 1983-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT71755A (en) | Process for preparing 4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase | |
| PT71368A (en) | Process for preparing 4-substituted-3-hydroxy-3-pirroline-2,5-dione inhibitors of glycolic acid oxidase | |
| ZA806788B (en) | 4-(5(and 4)-subsittuted-2-thienyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic and oxidase | |
| IE811431L (en) | Pyrazinyl oxadiazoles | |
| NO881697D0 (no) | Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene. | |
| ZA806787B (en) | 4-substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors ofglycolic acid oxidase | |
| AU2428484A (en) | Quinolone carboxylic acids | |
| DE3769066D1 (de) | Hydantoin-derivate zur behandlung von komplikationen bei diabetes. | |
| IL67235A (en) | 3-(1-substituted-4-piperidyl)-1,2-benzisoxazoles,a process for the preparation thereof,and pharmaceutical compositions comprising the same | |
| DE3788057D1 (de) | Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen. | |
| DE3886913D1 (de) | Verfahren zur Herstellung von flüssigen alkylierten 2-(2-Hydroxyphenyl)-benztriazol-Gemischen. | |
| ZA886097B (en) | Pharmaceutical composition for the treatment of psoriasis | |
| PT72772A (en) | Process for preparing 4-alkylsubstituted-3-hidroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase | |
| ZA806786B (en) | 4-substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase | |
| NO885287L (no) | Fremgangsmaate ved behandling av boreslam. | |
| HUT36783A (en) | Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane | |
| DE3787954D1 (de) | Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen. | |
| NO882546D0 (no) | Fremgangsmaate for beskyttelse av organer under kirurgiske operasjoner. | |
| ES8609326A1 (es) | Un procedimiento para la preparacion de nuevas 1-(aril sustituido)dihidro 1h pirrolizin-3,5-(h,6h)-dionas | |
| PT72802B (en) | Process for preparing alpha-methyldopa compositions | |
| NO892171D0 (no) | Fremgangsmaate for stabilisering, konsolidering og lagringav avfallsmaterialer. | |
| PL212775A1 (pl) | Zestaw do chirurgicznego leczenia zlaman kosci,zwlaszcza zuchwy |